Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
312.64B | 294.73B | 273.79B | 262.15B | 266.31B | 279.50B | Gross Profit |
282.43B | 288.04B | 268.12B | 255.34B | 258.60B | 269.50B | EBIT |
124.42B | 90.57B | 87.29B | 34.78B | 98.90B | 75.64B | EBITDA |
97.88B | 94.55B | 95.47B | 42.83B | 107.84B | 86.75B | Net Income Common Stockholders |
58.29B | 53.09B | 54.93B | 55.68B | 78.86B | 59.60B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
78.05B | 73.49B | 57.67B | 74.24B | 83.32B | 82.55B | Total Assets |
1.47T | 1.42T | 1.30T | 1.26T | 1.22T | 1.28T | Total Debt |
704.20B | 664.75B | 581.17B | 570.59B | 609.99B | 715.14B | Net Debt |
626.15B | 591.26B | 523.50B | 496.34B | 526.67B | 632.59B | Total Liabilities |
753.00B | 743.23B | 677.48B | 699.34B | 703.98B | 839.89B | Stockholders Equity |
661.86B | 628.01B | 581.09B | 531.88B | 485.68B | 415.32B |
Cash Flow | Free Cash Flow | ||||
0.00 | -41.39B | -6.00B | 41.61B | 109.83B | 16.05B | Operating Cash Flow |
0.00 | -36.76B | -1.32B | 46.09B | 113.18B | 19.70B | Investing Cash Flow |
0.00 | -6.18B | -2.69B | -4.03B | -4.57B | 6.21B | Financing Cash Flow |
0.00 | 57.16B | -12.93B | -50.16B | -108.79B | -24.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
€3.96B | 19.95 | 4.89% | 3.45% | ― | ― | ||
64 Neutral | $12.86B | 9.79 | 7.78% | 16985.65% | 12.28% | -7.82% | |
$1.93B | 14.96 | 4.16% | 3.88% | ― | ― | ||
$4.44B | 7.10 | 9.28% | 4.00% | ― | ― | ||
$3.77B | 16.53 | 10.51% | 4.53% | ― | ― | ||
€1.21B | 8.58 | 10.80% | 0.25% | ― | ― | ||
75 Outperform | ¥137.70B | 7.41 | 4.78% | 3.24% | -21.76% |